Boston Family Office LLC acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 98,027 shares of the financial services provider’s stock, valued at approximately $18,186,000. Marsh & McLennan Companies accounts for 1.2% of Boston Family Office LLC’s portfolio, making the stock its 27th largest position.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Solstein Capital LLC bought a new stake in shares of Marsh & McLennan Companies in the fourth quarter worth $25,000. KERR FINANCIAL PLANNING Corp acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter worth about $27,000. City Holding Co. acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter worth about $29,000. Headlands Technologies LLC acquired a new position in shares of Marsh & McLennan Companies during the 2nd quarter worth about $29,000. Finally, Financial Life Planners acquired a new position in shares of Marsh & McLennan Companies during the 3rd quarter worth about $32,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.
Marsh & McLennan Companies Trading Up 0.3%
NYSE:MRSH opened at $168.67 on Friday. The firm has a market capitalization of $81.49 billion, a PE ratio of 21.08, a P/E/G ratio of 2.45 and a beta of 0.62. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. Marsh & McLennan Companies, Inc. has a twelve month low of $156.60 and a twelve month high of $220.32.
Insider Activity
In other news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by corporate insiders.
Analyst Ratings Changes
MRSH has been the topic of several recent analyst reports. UBS Group lowered their price objective on shares of Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating on the stock in a research note on Tuesday. Barclays lowered their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. Wells Fargo & Company decreased their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 9th. Morgan Stanley decreased their price target on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a research note on Monday, April 6th. Finally, Raymond James Financial upgraded shares of Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price target on the stock in a research note on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $200.19.
Read Our Latest Stock Analysis on MRSH
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
